Unknown

Dataset Information

0

SARS-CoV-2 mutations: A strain on efficacy of neutralizing monoclonal antibodies?

ABSTRACT:

SUBMITTER: Boskovic M 

PROVIDER: S-EPMC8251443 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Structures from "Engineering Neutralizing SARS-CoV Antibodies to Bind SARS-CoV-2"
| S-BSST379 | biostudies-other
Unknown Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.
| S-EPMC7755170 | biostudies-literature
Unknown Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
| S-EPMC7506210 | biostudies-literature
Unknown Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.
| S-EPMC7332464 | biostudies-literature
Unknown Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies.
| S-EPMC8572761 | biostudies-literature
Genomics Potent neutralizing antibodies against SARS-CoV-2
| EGAS00001004412 | EGA
Unknown Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein.
| S-EPMC8353887 | biostudies-literature
Unknown Rapid development of neutralizing and diagnostic SARS-COV-2 mouse monoclonal antibodies.
| S-EPMC8102525 | biostudies-literature
Unknown Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2.
| S-EPMC7219369 | biostudies-literature
Unknown Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection.
| S-EPMC8201996 | biostudies-literature